Navigation Links
Drug May Extend Life When Breast Cancer Spreads
Date:5/26/2009

"That's why this comparison was being made." Gradishar, who was the lead author for the study, is also a consultant to Abraxis BioScience.

The chemotherapy drugs docetaxel, marketed as Taxotere, and paclitaxel are considered the gold standard for treating breast cancer that has spread to other parts of the body.

Abraxane, which is a variant of paclitaxel, uses a different, solvent-free "delivery" system to get the drug into the body.

For the study, 302 women who had not previously been treated for advanced breast cancer were randomized into one of four treatment arms. Three of the four groups were given Abraxane, administered one of three ways: every three weeks, weekly at a lower dose for three weeks with the fourth week off, or weekly at a higher dose for three weeks with the fourth week off. The fourth group was given Taxotere every three weeks at the standard dose.

Abraxane was found to be generally superior to Taxotere in response rates, but the most striking results were seen when the drug was given on a weekly schedule with the fourth week off.

"The anti-tumor effect was greater, and this is how the drug is very commonly used in practice today, although it's approved as an every-three-week drug," Gradishar said. "That also translated into a longer time until the disease progressed."

Abraxane also had fewer side effects than Taxotere, the researchers found. All-in-all, the authors stated, the results suggest that Abraxane may be a preferable first choice for treating this group of patients.

A phase 3 trial comparing the same set of drug regimens is being planned.

One expert noted that the weekly regimen appeared the best.

"This is slightly disappointing in that the every-three-weeks schedule was not as good. That's more convenient for patients," said Dr. Jennifer Eng-Wong, an assistant professor of oncology at Georgetown's Lombardi Comprehensive Cancer Center in Washing
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Weight-Loss Surgeries Extend Lives
2. Siemens Extends Tender Offer for Acquisition of Dade Behring
3. Global Med Technologies(R) Extends Its Worldwide Outreach
4. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Cancer control in Europe works; now it is time to extend it to poorer countries
7. ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
8. NIH/NCI renews and extends nationwide license for Genomatix software and databases
9. Design Resource Extends Support for Orthopaedic and Cardiovascular Devices
10. Summer Temperatures Linger, Extend Threat of Parasites
11. Pelosi Statement on House Vote to Extend Family and Medical Leave for Military Families
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug May Extend Life When Breast Cancer Spreads
(Date:3/30/2015)... 2015 According to a recently published ... repair market will continue to dominate the European soft ... due to increasing numbers of ventral hernias, and the ... “The significantly large market share represented by ventral hernia ... We’re seeing a growing use of expensive biologics,” explains ...
(Date:3/30/2015)... This report studies the global tumor ablation ... 2019. , Based on the type of technology, ... four major segments, namely radio-frequency, microwave, cryoablation and ... laser ablation) segments. Moreover, based on type of ... into three segments, namely, interventional radiology, surgery and ...
(Date:3/30/2015)... 2015 On March 19th, 2015, in ... of the Detroit Lions, LiveToBeSober.org hosted the “Fighting Addiction ... ministers and bishops as well as other civic leaders ... at the luncheon, including retired Detroit Lions wide receiver ... and two survivors of their own personal battles with ...
(Date:3/30/2015)... Pa. (PRWEB) March 30, 2015 ... the Halal certification for all current Epax® Ultra ... facility in Ålesund, Norway. The certification ensures the ... comply with the Islamic religious regulations for Halal. ... step in FMC’s efforts to further advance its ...
(Date:3/30/2015)... GenSight ®, provider of an Enterprise Portfolio ... The Forrester Wave™: Strategic Planning For The [Business Technology] ... positions GenSight as a leader and gave the company ... the analytics, corporate strategy, assessment, direction and life cycle ... the Leaders category. , According to the report: ...
Breaking Medicine News(10 mins):Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 3Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2Health News:FMC Health and Nutrition Announces Halal Certification for Epax® Brand Omega-3 Ingredients 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 3
... that ravaged medieval Europe has a weakness that could help ... a study published on Thursday. ,A bacterium known ... Death spread when people are bitten by an infected flea, ... coughing or sneezing. ,There are periodic natural outbreaks ...
... comes to some of today’s health issues, 100 percent ... related to certain diseases – concludes// a study by ... ability to reduce risk compared to their whole fruit/vegetable ... conducted the literature review. The researchers analyzed a variety ...
... heavily on alternative therapists who mistreat their patients sexually ... therapists said to exist in Britain and there are ... On the other hand, completely qualified medical practitioners who ... rules and guidelines regarding their relationship with their patients. ...
... have a longer average lifespan than most of the men ... where it is usually reported// that people live longer on ... social policy study published on Wednesday, healthy Israeli men live ... than men, average lifespan of 82.4 years, on par with ...
... A US government funded study finds that CT scans used ... to be replaced by MRI scans which are better in ... should now be passed to magnetic resonance imaging,” wrote Dr. ... in Australia in a note accompanying the study report. ...
... presentation into Japanese for an American client who wants to ... not many can undertake. //And all this from Chennai too! ... proving that it is possible. Specialising in providing software services ... on the dot and raking in millions of dollars in ...
Cached Medicine News:Health News:Scientists Find Potential Weakness In Plague Germ 2Health News:Benefits of Fruit and Vegetable Juices 2Health News:Cashing in on IT for Healthcare 2
(Date:3/30/2015)... OF PRUSSIA, Pa. , March 30, 2015 ... the European Medicines Agency (EMA) has started the ... Application (MAA) for its long-acting fusion protein linking ... Upon European Commission approval, rIX-FP will provide hemophilia ... well as the European Economic Area (EEA) countries, ...
(Date:3/30/2015)... , March 30, 2015  BioPharmX Corporation (OTCQB: ... development of novel drug delivery products to address ... today announced the appointment of Stephen Morlock ... veteran, to its board of directors.  Mr. Morlock,s ... to expand its national roll-out of Violet iodine, ...
(Date:3/30/2015)... 30, 2015 Beta-O2 ... as the company,s new chief executive officer. Dr. ... leading early stage Israeli venture capital firm. He is ... and vascular surgery.        (Logo: http://photos.prnewswire.com/prnh/20140910/705638) ... Sherpa Innoventures is Beta-O2,s newest investor, having participated in ...
Breaking Medicine Technology:European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 2European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 3European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 4BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3Beta-O2 Names Dr. Yuval Avni CEO 2Beta-O2 Names Dr. Yuval Avni CEO 3
... 5, 2011 Jennerex, Inc., a private clinical-stage ... of first-in-class targeted oncolytic products for cancer, and ... specialized in the development of immunotherapeutic products, today ... 2 clinical studies of JX-594 were presented in ...
... Pharmaceuticals, Inc. (NASDAQ: QCOR ) today announced preliminary ... The Company announced the preliminary metrics in advance of the ... Executive Officer of Questcor, will present on Tuesday, April 5, ... web cast of the presentation during or after the event, ...
Cached Medicine Technology:Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 2Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 3Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 4Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 5Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 2Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 3Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 4Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 5Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 6Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 7Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 8
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
New - Color Coded Berman Airways. A simple idea makes size identification easier for you., ,Premium upgrade without a premium price. Color Coded Berman airways are latex-free., ,Plastic. Single use...
Plastic Economical Single use. Non-Sterile....
Medicine Products: